Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years ...

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are ...

KØBENHAVN, DK / ACCESS Newswire / November 24, 2025 / FluoGuide A/S (STO:FLUO)("FluoGuide" or the "Company" held an extraordinary general meeting on 24 November 2025.To the shareholders of FluoGuide A ...

RINJ claims full and unfettered freedom in the exercise of its functions.

An Oban granny has told how she is ’crippled’ by an agonising oesophagus disorder - that can only be remedied by eating Love ...

Alongside scientific innovation, ESMO 2025 emphasised the need for global collaboration in regulatory alignment and clinical ...

More than 10% of Tennesseans live with chronic obstructive pulmonary disease (COPD), a long-term, progressive lung disease that causes difficulty breathing. In fact, Tennessee is one of the top 10 ...

Jefferies London Healthcare Conference 2025 November 19, 2025 4:30 AM ESTCompany ParticipantsTony Wood - Chief Scientific Officer and Head ...

Nine percent of Alabamans live with chronic obstructive pulmonary disease (COPD) a long-term, progressive lung disease that causes difficulty breathing. In fact, Alabama is one of the top 10 states in ...

More than 8% of Hoosiers live with chronic obstructive pulmonary disease (COPD), a long-term, progressive lung disease that causes difficulty breathing. In fact, Indiana is one of the top 10 states in ...

COPD is a group of lung diseases that get worse over time. It prevents airflow to the lungs, causing breathing problems and ...

Early detection and innovative biologic treatment can prevent hospitalizations, improve quality of life, and extend the ...